Opinion|Videos|August 9, 2024
Comparing and Contrasting the Characteristics of the FDA-Approved Pneumococcal Vaccines
The pneumococcal vaccination experts offer a comparative analysis of the five FDA-approved pneumococcal vaccines, focusing on their structural differences and the specific strains each vaccine targets.
Advertisement
Episodes in this series
- Please compare the 5 currently FDA-approved pneumococcal vaccines with regards to vaccine structure and how the strains they target differ.
- How is the structure of covalent different from the structure of conjugate products.
- How is the structure of covalent different from the structure of conjugate products.
Advertisement
Related to this article
Authors of a pharmacist-directed transitions-of-care study discuss what drives pneumococcal vaccine hesitancy and how pharmacists can build systematic vaccine screening into inpatient workflows.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Nearly Two-Thirds of Patients With Long COVID Meet Diagnostic Criteria for POTS
2
After 180 Years, Multiple Myeloma Gets a Definition of Cure
3
Harnessing the Gut Microbiome for Enhanced CAR T Cell Therapy
4
Building a BCMA Bispecific Around the Patient Experience, Not Just the Molecule
5